Protection of Pioglitazone against Podocyte Injury in STZ-Induced Diabetic Rats
KUANG Lei,YE Shan-dong,XING Yan
2013-01-01
Abstract:Objective To investigate the protection against podocyte injury and the relation with anti-inflammatory action by different dosages of hydrochloride pioglitazone in Diabetic Nephropathy(DN) rats.Methods Diabetic rats were randomly divided into following four groups: diabetic model rats(DM group,n=8),pioglitazone(PIO,10,20 and 30 mg/(kg·d),respectively)-treated diabetic rats(DR1,DR2 and DR3 group,n=8),8 healthy rats were served as a normal control group(NC group).10 ml urine specimen was collected to test urinary albumin(Ualb),urinary sediment nephrin(Unep),urinary monocyte chemoattractant protein-1(UMCP-1) and urinary creatinine(UCr) at the basal and 8th weeks.To eliminate the impact of urine volume,the parameters mentioned above were expressed as Ualb/Ucr(UACR),Unep/Ucr(UNER),Umcp-1/Ucr(UMCR).At the 8th week,glycated haemoglobin(HbA1c) levels were assessed and renal tissue nephrin and MCP-1 protein expression were determined by immunohistochemistry.Results ①The blood glucose(BG) levels throughout the study period along with HbA1c in diabetic rats were significantly higher than those in group NC(P<0.05),whereas no significant differences among group DR1,DR2 DR3 and group DM.②At the 8th week,the levels of UACR,UNER and UMCR decreased significantly in PIO-treatment groups compared with group DM,in addition,the parameters mentioned above in group DR2 and DR3 were lower than those in group DR1(P<0.05),whereas no significant differences were found between DR2 and DR3 group;The level of renal nephrin protein: NC group>PIO-treated groups>DM group(P<0.05),no differences among PIO-treated groups.The level of renal MCP-1 protein: DM group>PIO-treated groups>NC group(P<0.05),whereas no different among PIO-treated groups.③UNER was positively correlated with UMCR(r=0.729,P<0.01).The expression of renal nephrin protein was negatively correlated with renal MCP-1 protein(r=-0.696,P<0.01).Conclusion Pioglitazone has a clear protective effect on podocytes of diabetic rats with certain dose dependent,which may be related to its effect in reducing local inflammation beyond its hypoglycemic effect.